← Leaderboards
Todd W Rice
Vanderbilt University
$4,849,871
Attributed
$4,849,871
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $789.7K · FY2006–20$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,849,871 · 4
By mechanism
U01$2,249,466 · 1
R01$1,155,199 · 1
K23$758,806 · 1
R34$686,400 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- William O. Richards$2,600,709
- Leo Cheng$1,872,650
- Andrew J Pullan$1,612,898
- Frederick E Barr$948,754
- Jason D. Morrow$8,525,350
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelProceduresPreventStructureClinical TrialsProtocols DocumentationOperationLeadershipFoundationsPatient RecruitmentsDesignSepsisMedicalFutureRicePreventionPneumoniaMorbidity - Disease RateFunctional DisorderOrganEnteralOrgan FailureLength Of StayCoupled
Grant awards (18)
Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network$369,497
U01 · FY2020 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network$369,497
U01 · FY2019 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network$369,497
U01 · FY2018 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network$376,978
U01 · FY2017 · HL · contact PI
Using real world decisions to develop a modified central IRB model$412,690
R01 · FY2016 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network$376,978
U01 · FY2016 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network$387,019
U01 · FY2015 · HL · contact PI
Using real world decisions to develop a modified central IRB model$280,517
R01 · FY2015 · HL · contact PI
Using real world decisions to develop a modified central IRB model$91,529
R01 · FY2015 · HL · contact PI
Using real world decisions to develop a modified central IRB model$370,463
R01 · FY2014 · HL · contact PI
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis$305,760
R34 · FY2014 · HL · contact PI
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis$185,640
R34 · FY2013 · HL · contact PI
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis$195,000
R34 · FY2012 · HL · contact PI
Attenuating Inflammation via Protein-Calorie Restriction$151,929
K23 · FY2010 · HL · contact PI
Attenuating Inflammation via Protein-Calorie Restriction$151,929
K23 · FY2009 · HL · contact PI
Attenuating Inflammation via Protein-Calorie Restriction$151,929
K23 · FY2008 · HL · contact PI
Attenuating Inflammation via Protein-Calorie Restriction$151,090
K23 · FY2007 · HL · contact PI
Attenuating Inflammation via Protein-Calorie Restriction$151,929
K23 · FY2006 · HL · contact PI